Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal DiseaseWan‐Long Chuang, Alessandra Mangia, Peter Buggisch et al.|The American Journal of Gastroenterology|2021Cited by 11